Lange-Konior K
Katedry i Zakładu Medycyny Sadowej, Pomorskiej Akademii Medycznej w Szczecinie.
Ann Acad Med Stetin. 1999;45:41-54.
The aim of the paper was to evaluate the activity of inhibitor of the phytoagglutinin Pisum sativum (IfPs) in sera of mothers' and umbilical blood of their newborns in confrontation with the course of pregnancy and delivery. The investigations involved 152 tests of sera collected from women delivering at Department of Obstetrics and Perinatology in the Institute of Gynecology and Obstetrics PMU in Szczecin in the years 1992-1993, as well as 156 samples of sera stemming from their newborn infants and were taken from the umbilical cord vessels. The method of investigations being used in the paper was the reaction of inhibiting the phytohemagglutination, wherein the inhibiting action of sera in bearing women and of sera in umbilical blood exerted on agglutinating one was assessed in relation to human erythrocytes of the group 0 with Pisum sativum lectin properties. The accepted titer of inhibitor of the agglutinin Pisum sativum (IfPs) was expressed as the highest dilution of serum, at which complete inhibition of phytohemagglutination was still preserved. The performed investigations have disclosed statistically significant differences between the activity of IfPs occurring in sera of the mothers and the inhibiting factor in umbilical blood sera of the newborns (Tab. 1). No effect of the duration of pregnancy and the course of pregnancy on the IfPs activity in sera of mothers was disclosed. The absence of inhibitor of Pisum sativum lectin in umbilical blood sera was essentially frequently recorded in premature termination of pregnancy between 31-37 weeks of its duration as well as in sera of newborns born by cesarean section and newborns with birth mass being equal or lower than 2500 g in comparison to sera of full term newborns born by forces of nature (Tab. 2, 3, 5). The birth status of newborns according to Apgar scale did not have any influence of IfPs activity in their sera, however, IfPs activity in sera of umbilical blood was statistically significantly more frequent in cases of deliveries lasting longer than 4 hours as compared to its activity in cases of deliveries being shorter than 4 hours (Tab. 4). On the basis of results of the performed investigations it has been revealed that at the period of intensive divisions of cells, their differentiation (intrauterine period of fetal development) the activity of the inhibitors of phytohemagglutination appearing in body fluids of human being is residual only or does not appear at all. The IfPs activity was intensifying with the progress of intrauterine maturation of the fetus. In the paper closer attention was focussed on the new point of view concerning the role of phytoagglutinins and endogenic lectins as well as their inhibitors in various pathological processes particularly neoplastic ones.
本文旨在评估豌豆凝集素抑制剂(IfPs)在母亲血清及新生儿脐血中的活性,并将其与妊娠和分娩过程进行对比研究。研究对象包括1992 - 1993年在什切青市波美拉尼亚医科大学妇产科研究所产科和围产医学科分娩的152名妇女的血清样本,以及从她们新生儿的脐带血管采集的156份血清样本。本文采用的研究方法是抑制植物血凝反应,即评估孕妇血清和脐血血清对具有豌豆凝集素特性的0型人红细胞凝集作用的抑制效果。豌豆凝集素抑制剂(IfPs)的有效效价以血清的最高稀释度表示,在此稀释度下植物血凝反应仍能完全被抑制。研究结果显示,母亲血清中IfPs的活性与新生儿脐血血清中的抑制因子之间存在统计学显著差异(表1)。未发现妊娠时长和妊娠过程对母亲血清中IfPs活性有影响。与自然分娩的足月新生儿血清相比,在妊娠31 - 37周早产、剖宫产出生的新生儿以及出生体重等于或低于2500克的新生儿的脐血血清中,豌豆凝集素抑制剂的缺失情况更为常见(表2、3、5)。新生儿根据阿普加评分的出生状况对其血清中IfPs的活性没有任何影响,然而,与分娩时长小于4小时的情况相比,分娩时长超过4小时的情况下,脐血血清中IfPs的活性在统计学上更为常见(表4)。根据所进行的研究结果表明,在细胞密集分裂、分化的时期(胎儿发育的宫内期),人体体液中出现的植物血凝反应抑制剂的活性仅处于残余状态或根本不出现。随着胎儿宫内成熟的进展,IfPs的活性增强。本文更密切关注了关于植物凝集素和内源性凝集素及其抑制剂在各种病理过程,特别是肿瘤性病理过程中的作用的新观点。